Gut microbiota in Parkinson's disease: Temporal stability and relations to disease progressionResearch in context

Cited by papers we hold 9

• Parkinson’s disease and gut microbiota: from clinical to mechanistic and therapeutic studies · 2023
  No notice
• Fecal microbiota transplantation in Parkinson's disease—A randomized repeat-dose, placebo-controlled clinical pilot study · 2023
  No notice
• Role of Microbiota-Gut-Brain Axis in Regulating Dopaminergic Signaling · 2022
  No notice
• Gut Microbiota: A Novel Therapeutic Target for Parkinson’s Disease · 2022
  No notice
• Gut bacterial profiles in Parkinson's disease: A systematic review · 2022
  No notice
• The Association Between the Gut Microbiota and Parkinson's Disease, a Meta-Analysis · 2021
  No notice
• Fecal microbiota transplantation protects rotenone-induced Parkinson’s disease mice via suppressing inflammation mediated by the lipopolysaccharide-TLR4 signaling pathway through the microbiota-gut-brain axis · 2021
  No notice
• Meta-analysis of the Parkinson’s disease gut microbiome suggests alterations linked to intestinal inflammation · 2021
  No notice
• Diet in Parkinson's Disease: Critical Role for the Microbiome · 2019
  No notice

Reads

A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.